There are no significant differences in outcomes post-AMI in patients with systemic lupus erythematosus vs the general population.

There are sex-specific differences for risk factors, hospitalization rates, and in-hospital mortality in patients with stroke.

GLP-1 receptor agonists do not affect cardiovascular, kidney, or safety outcomes regardless of SGLT2 inhibitor use in patients with type 2 diabetes.

Diabetes and excessive weight are independent risk factors for adult asthma that have the potential to be modified.

Patients aged 10 to 17 years who are prescribed GLP-1 RAs are more likely to have comorbid type 2 diabetes and more.

Facial volume loss and increased skin laxity were significant in the mid-cheek region after major weight loss, resulting in accelerated facial aging.

Patients with T2D with more severe peripheral neuropathy have a 4-fold DED risk compared with patients with mild or no peripheral neuropathy.

A look into ways AI technology in cardiology is evolving & how it can be applied to patient management & care as it continues ...

Treatment strategies have not been well established for thrombotic microangiopathy associated with malignant hypertension.

Most physicians adhere to guideline-directed medical therapies for HFrEF based on the 2021 European Society of Cardiology HF guidelines.

Metformin use, compared with no use, was associated with a lower risk for uterine fibroids among women with diabetes.

Comorbid diabetes was linked to worse functional and mortality outcomes, including maximum oxygen consumption, among patients with heart failure.